Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/1b Study of Single and Multiple Ascending Doses of TLC 6740 in Healthy Subjects, Including Evaluation of Food Effect and Potential Drug-Drug Interactions, and Preliminary Safety and Efficacy in Subjects With Obesity, With or Without Diabetes

NCT05822544 is registered in ClinicalTrials.gov with OrsoBio, Inc as lead sponsor.

NCT NCT05822544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05822544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/1b Study of Single and Multiple Ascending Doses of TLC 6740 in Healthy Subjects, Including Evaluation of Food Effect and Potential Drug-Drug Interactions, and Preliminary Safety and Efficacy in Subjects With Obesity, With or Without Diabetes
Lead sponsor
OrsoBio, Inc
Phase
Phase 1
Overall status
Active, not recruiting
Start date
April 22, 2023
Completion date
January 31, 2027
Enrollment
564 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects, obesity, type 2 diabetes